Indian-origin psychiatrist and former CEO of Sovereign Health Group, Tonmoy Sharma, was arrested at Los Angeles International Airport in connection with a staggering $149 million healthcare fraud. Sharma, 61, originally from Guwahati, Assam, was taken into custody on May 29 following an eight-count federal grand jury indictment that includes charges of wire fraud, conspiracy, and illegal kickbacks. According to federal prosecutors, Sharma’s company, Sovereign Health, engaged in a systematic scheme of submitting fraudulent claims to health insurers and paying millions in unlawful incentives to generate patient referrals.
The US Attorney’s Office of the Central District of California stated that Sharma was involved in billing insurers for unauthorized and medically unnecessary urinalysis tests, generating more than $29 million in fraudulent claims. In addition to these activities, Sharma allegedly paid over $21 million in illegal kickbacks to recruiters and treatment facilities to secure patient referrals, violating federal anti-kickback statutes. His co-defendant in the case, Paul Jin Sen Khor, has also been arrested and pleaded not guilty, with his trial scheduled for July 29.
The case is the outcome of a long-standing federal investigation into Sovereign Health Group, which began in June 2017. The company, now defunct, operated multiple addiction treatment centers across Southern California. In the early phase of the probe, the FBI conducted raids on the company's San Clemente headquarters, treatment centers, and Sharma’s residence in San Juan Capistrano. The company ceased operations in 2018 amid mounting legal and regulatory scrutiny.
Tonmoy Sharma was a well-known figure in the field of psychiatry before his legal troubles. He earned his MBBS from Dibrugarh Medical College, Assam, in 1987, and later received his medical license from both the Indian Medical Council and the General Medical Council in the UK. He went on to establish a strong academic and clinical presence in the United Kingdom before shifting to the United States, where he eventually founded Sovereign Health.
Renowned internationally as a leading research psychiatrist, Sharma's contributions to the study and treatment of schizophrenia earned him considerable respect. His focus lay in understanding brain function, cognition, and behavioral patterns in psychiatric disorders. He was a prolific academic, having authored over 200 peer-reviewed journal articles, co-authored five books on schizophrenia, and served on editorial boards and advisory groups related to antipsychotic treatments. Over his career, he directed more than 20 clinical trials related to mental health and brain sciences.
Despite his academic acclaim, Sharma’s professional reputation took a dramatic fall with the criminal allegations brought against him. Federal prosecutors assert that Sharma used his position to manipulate vulnerable individuals by fraudulently enrolling them into insurance programs without their knowledge and leveraging deceptive tactics to generate financial gains. These schemes not only compromised the integrity of the healthcare system but also violated numerous ethical and legal standards.
Tonmoy Sharma’s arrest represents one of the largest cases of healthcare fraud involving an Indian-origin professional in the United States. While his defense is yet to be presented in court, the gravity of the charges reflects a calculated pattern of deceit and exploitation. If convicted, Sharma faces significant prison time and financial penalties, which could permanently tarnish his once-prominent standing in the medical and academic communities.
The unfolding case against Sharma highlights the increasing federal crackdown on fraudulent practices within the healthcare industry, particularly those involving addiction treatment and mental health services. The outcome of the trial could also serve as a precedent for future prosecutions related to medical billing fraud and illegal referral arrangements. As the legal process continues, the scandal remains a shocking chapter in the life of a man who once stood at the forefront of psychiatric research and treatment innovation.
